Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Leg After a Stroke (PLUS)

This study is ongoing, but not recruiting participants.

Sponsor:

Information provided by (Responsible Party):

Merz Pharmaceuticals GmbH

ClinicalTrials.gov Identifier:

NCT01464307

First received: November 1, 2011

Last updated: February 18, 2015

Last verified: February 2015

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	July 2015
Primary Completion Date:	August 2014 (Final data collection date for primary outcome measure)